Matches in SemOpenAlex for { <https://semopenalex.org/work/W3183485133> ?p ?o ?g. }
- W3183485133 endingPage "102898" @default.
- W3183485133 startingPage "102898" @default.
- W3183485133 abstract "To study whether adding repeated 125 mg methyl-prednisolone pulses (MP) to Eurolupus fortnightly intravenous cyclophosphamide (CYC) improves remission of lupus nephritis (LN) compared with recommended schedules. Observational comparative study of patients with biopsy-confirmed class III, IV or V LN: 30 in the mycophenolate (MMF) group, 25 in the CYC group and 38 in the CYC-MP group. The main efficacy outcome was complete response at 12 months. Patients in the CYC-MP group received lower doses of prednisone within 6 months (mean 8.5 mg/d, vs. 15 mg/d in the MMF group vs. 24 mg/d in the CYC group, respectively). The complete response rates at 12 months were: CYC-MP 86%; CYC 56%; MMF 47% (p = 0.002) at Pr/Cr <0.5; CYC-MP 86%; CYC 65%; MMF 63% (p = 0.07) at Pr/Cr ≤0.7. The cumulative 12-month response rates for the CYC-MP, CYC and MMF groups were, respectively, 0.90, 0.58 and 0.63 (p = 0.004). In the adjusted Cox model, patients receiving CYC-MP were more likely to achieve complete response at Pr/Cr <0.5 than those in the MMF (HR vs. CYC-MP 0.33, 95%CI 0.16-0.65) and the CYC groups (HR vs. CYC-MP 0.47, 95%CI 0.21-1.04). Glucocorticoid-related toxicity was seen in 2.6% of the CYC-MP group, 24% of the CYC group and 20% of the MMF group (p = 0.029). The addition MP of 125 mg to each fortnightly dose of 500 mg of CYC improves response rates and reduces the need for oral glucocorticoids in patients with class III, IV and V LN." @default.
- W3183485133 created "2021-08-02" @default.
- W3183485133 creator A5003842978 @default.
- W3183485133 creator A5013594957 @default.
- W3183485133 creator A5014565888 @default.
- W3183485133 creator A5018396975 @default.
- W3183485133 creator A5031530191 @default.
- W3183485133 creator A5038417813 @default.
- W3183485133 creator A5050883060 @default.
- W3183485133 creator A5058263369 @default.
- W3183485133 creator A5059054921 @default.
- W3183485133 creator A5061482669 @default.
- W3183485133 creator A5074946745 @default.
- W3183485133 creator A5075236193 @default.
- W3183485133 date "2021-10-01" @default.
- W3183485133 modified "2023-10-18" @default.
- W3183485133 title "Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III, IV and V lupus nephritis" @default.
- W3183485133 cites W1830546365 @default.
- W3183485133 cites W1963756694 @default.
- W3183485133 cites W2014368772 @default.
- W3183485133 cites W2025393559 @default.
- W3183485133 cites W2038017915 @default.
- W3183485133 cites W2073246129 @default.
- W3183485133 cites W2095671546 @default.
- W3183485133 cites W2096194879 @default.
- W3183485133 cites W2138889351 @default.
- W3183485133 cites W2141044946 @default.
- W3183485133 cites W2159860161 @default.
- W3183485133 cites W2160382588 @default.
- W3183485133 cites W2175492537 @default.
- W3183485133 cites W2298285162 @default.
- W3183485133 cites W2527593748 @default.
- W3183485133 cites W2617087217 @default.
- W3183485133 cites W2735747960 @default.
- W3183485133 cites W2900364017 @default.
- W3183485133 cites W2927871970 @default.
- W3183485133 cites W2961762280 @default.
- W3183485133 cites W2993632753 @default.
- W3183485133 cites W3013081823 @default.
- W3183485133 cites W3035306856 @default.
- W3183485133 cites W3085025551 @default.
- W3183485133 cites W3113164568 @default.
- W3183485133 cites W3131168516 @default.
- W3183485133 cites W4211168185 @default.
- W3183485133 doi "https://doi.org/10.1016/j.autrev.2021.102898" @default.
- W3183485133 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34274543" @default.
- W3183485133 hasPublicationYear "2021" @default.
- W3183485133 type Work @default.
- W3183485133 sameAs 3183485133 @default.
- W3183485133 citedByCount "12" @default.
- W3183485133 countsByYear W31834851332022 @default.
- W3183485133 countsByYear W31834851332023 @default.
- W3183485133 crossrefType "journal-article" @default.
- W3183485133 hasAuthorship W3183485133A5003842978 @default.
- W3183485133 hasAuthorship W3183485133A5013594957 @default.
- W3183485133 hasAuthorship W3183485133A5014565888 @default.
- W3183485133 hasAuthorship W3183485133A5018396975 @default.
- W3183485133 hasAuthorship W3183485133A5031530191 @default.
- W3183485133 hasAuthorship W3183485133A5038417813 @default.
- W3183485133 hasAuthorship W3183485133A5050883060 @default.
- W3183485133 hasAuthorship W3183485133A5058263369 @default.
- W3183485133 hasAuthorship W3183485133A5059054921 @default.
- W3183485133 hasAuthorship W3183485133A5061482669 @default.
- W3183485133 hasAuthorship W3183485133A5074946745 @default.
- W3183485133 hasAuthorship W3183485133A5075236193 @default.
- W3183485133 hasConcept C126322002 @default.
- W3183485133 hasConcept C2776694085 @default.
- W3183485133 hasConcept C2776715498 @default.
- W3183485133 hasConcept C2776755627 @default.
- W3183485133 hasConcept C2778720950 @default.
- W3183485133 hasConcept C2779134260 @default.
- W3183485133 hasConcept C2779912601 @default.
- W3183485133 hasConcept C71924100 @default.
- W3183485133 hasConcept C90924648 @default.
- W3183485133 hasConcept C98274493 @default.
- W3183485133 hasConceptScore W3183485133C126322002 @default.
- W3183485133 hasConceptScore W3183485133C2776694085 @default.
- W3183485133 hasConceptScore W3183485133C2776715498 @default.
- W3183485133 hasConceptScore W3183485133C2776755627 @default.
- W3183485133 hasConceptScore W3183485133C2778720950 @default.
- W3183485133 hasConceptScore W3183485133C2779134260 @default.
- W3183485133 hasConceptScore W3183485133C2779912601 @default.
- W3183485133 hasConceptScore W3183485133C71924100 @default.
- W3183485133 hasConceptScore W3183485133C90924648 @default.
- W3183485133 hasConceptScore W3183485133C98274493 @default.
- W3183485133 hasIssue "10" @default.
- W3183485133 hasLocation W31834851331 @default.
- W3183485133 hasLocation W31834851332 @default.
- W3183485133 hasOpenAccess W3183485133 @default.
- W3183485133 hasPrimaryLocation W31834851331 @default.
- W3183485133 hasRelatedWork W145182360 @default.
- W3183485133 hasRelatedWork W1912221966 @default.
- W3183485133 hasRelatedWork W1975848259 @default.
- W3183485133 hasRelatedWork W1982830518 @default.
- W3183485133 hasRelatedWork W2004932524 @default.
- W3183485133 hasRelatedWork W2035344267 @default.
- W3183485133 hasRelatedWork W2035346449 @default.
- W3183485133 hasRelatedWork W2304344236 @default.